Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10,755 GBX | +0.12% | +3.03% | +1.36% |
Mar. 27 | AstraZeneca CEO Sees No Impact from Biosecure Act | MT |
Mar. 27 | AstraZeneca's RSV Disease Drug, Breast Cancer Combination Therapy Receive Approval in Japan | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.36% | 210B | |
+33.50% | 701B | |
+26.24% | 571B | |
+0.78% | 381B | |
+20.85% | 334B | |
+16.38% | 319B | |
+2.70% | 210B | |
-6.95% | 201B | |
-3.51% | 157B | |
-0.60% | 153B |
- Stock
- Equities
- Stock AstraZeneca PLC - London S.E.
- News AstraZeneca PLC
- AstraZeneca : Enhertu Treatment for Metastatic Gastric Cancer Gains Approval in US